CA2262564A1 - Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition - Google Patents

Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition Download PDF

Info

Publication number
CA2262564A1
CA2262564A1 CA002262564A CA2262564A CA2262564A1 CA 2262564 A1 CA2262564 A1 CA 2262564A1 CA 002262564 A CA002262564 A CA 002262564A CA 2262564 A CA2262564 A CA 2262564A CA 2262564 A1 CA2262564 A1 CA 2262564A1
Authority
CA
Canada
Prior art keywords
oligosaccharide
derivative
elastin
lymphocytes
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002262564A
Other languages
English (en)
French (fr)
Inventor
Ladislas Robert
Alexandre Robert
Dominique Castelli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roc AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2262564A1 publication Critical patent/CA2262564A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002262564A 1996-07-31 1997-07-30 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition Abandoned CA2262564A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9609649A FR2751876B1 (fr) 1996-07-31 1996-07-31 Utilisation d'un oligosaccharide comme immunomodulateur, composition dermato-cosmetique et methode de traitement cosmetique
FR96/09649 1996-07-31
PCT/IB1997/000951 WO1998004270A1 (en) 1996-07-31 1997-07-30 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition

Publications (1)

Publication Number Publication Date
CA2262564A1 true CA2262564A1 (en) 1998-02-05

Family

ID=9494678

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002262564A Abandoned CA2262564A1 (en) 1996-07-31 1997-07-30 Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition

Country Status (15)

Country Link
EP (1) EP0954322A1 (zh)
JP (1) JP2000516591A (zh)
KR (1) KR20000029754A (zh)
CN (1) CN1228705A (zh)
AU (1) AU3457697A (zh)
BR (1) BR9710630A (zh)
CA (1) CA2262564A1 (zh)
CZ (1) CZ29599A3 (zh)
FR (1) FR2751876B1 (zh)
HU (1) HUP9903904A3 (zh)
NZ (1) NZ333985A (zh)
PL (1) PL331478A1 (zh)
RU (1) RU99104398A (zh)
SK (1) SK12199A3 (zh)
WO (1) WO1998004270A1 (zh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1514551A4 (en) * 2002-05-31 2008-01-09 Amano Enzyme Inc ANTI-INFLAMMATORY, AGENT TO COMBAT ALLERGIC DISEASES, AND FUNCTIONAL FOOD
EP2123282A3 (en) * 2003-10-24 2010-01-20 N.V. Nutricia Immunemodulating oligosaccharides
JP2005281298A (ja) * 2004-03-04 2005-10-13 Fancl Corp メリビオースを有効成分とするｔ細胞免疫調節剤
EP1597978A1 (en) * 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
EP2012807A4 (en) * 2006-04-10 2009-07-08 Dikovskiy Aleksander Vladimiro PHARMACEUTICAL COMPOSITION FROM AN ENTEROSORBEN AND PREBIOTIKA, DOSAGE FORMS AND METHOD FOR THE PREVENTION AND TREATMENT OF GASTROINTESTINAL DISEASES
GB0915315D0 (en) 2009-09-03 2009-10-07 Univ Manchester Use of non-digestible oligosaccharides
GB2500585A (en) * 2012-03-23 2013-10-02 Univ Manchester Use of oligosaccharides to reduce skin pigmentation
EP3060222A4 (en) 2013-10-25 2017-07-05 Red Pinnace Limited Dietary regime for treatment of acne and other inflammatory skin conditions
US11328621B2 (en) 2013-10-25 2022-05-10 Red Pinnace Limited Dietary regime for treatment of acne and other inflammatory skin conditions
KR101689875B1 (ko) 2014-08-28 2016-12-26 (주)셀아이콘랩 펩타이드와 아미노산의 혼합물을 함유하는 아토피 개선용 화장료 조성물
KR101689877B1 (ko) 2014-08-28 2016-12-26 (주)셀아이콘랩 아토피 개선용 화장료 조성물
KR102046566B1 (ko) 2018-08-09 2019-11-19 박정혜 피부 가려움 개선용 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545087B1 (fr) * 1983-04-29 1985-12-27 Malte Oeuvres Hospit Fses Ordr Nouveaux derives glucidiques du 5-hydroxytryptophane, obtention et application comme medicaments
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
JP2823358B2 (ja) * 1992-05-26 1998-11-11 アルバータ リサーチ カウンスル 免疫抑制性および寛容原性修飾ルイス▲上ｃ▼およびＬａｃＮＡｃ化合物

Also Published As

Publication number Publication date
FR2751876B1 (fr) 1998-12-31
FR2751876A1 (fr) 1998-02-06
HUP9903904A2 (hu) 2000-04-28
PL331478A1 (en) 1999-07-19
EP0954322A1 (en) 1999-11-10
HUP9903904A3 (en) 2000-05-29
AU3457697A (en) 1998-02-20
CZ29599A3 (cs) 1999-06-16
CN1228705A (zh) 1999-09-15
JP2000516591A (ja) 2000-12-12
WO1998004270A1 (en) 1998-02-05
SK12199A3 (en) 2000-01-18
RU99104398A (ru) 2001-02-20
BR9710630A (pt) 2000-01-11
KR20000029754A (ko) 2000-05-25
NZ333985A (en) 2000-09-29

Similar Documents

Publication Publication Date Title
Brattig et al. Lipopolysaccharide-like molecules derived from Wolbachia endobacteria of the filaria Onchocerca volvulus are candidate mediators in the sequence of inflammatory and antiinflammatory responses of human monocytes
CA2262564A1 (en) Use of an oligosaccharide as an immunomodulator in a dermato-cosmetic composition
De Vries et al. Mast cell degranulation breaks peripheral tolerance
Smith et al. Isolation and purification of CD14-negative mucosal macrophages from normal human small intestine
Parhar et al. Suppression of lymphocyte alloreactivity by early gestational human decidua: I. Characterization of suppressor cells and suppressor molecules
Shannon et al. Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative
Li et al. CTLA4 engagement is required for induction of murine liver transplant spontaneous tolerance
Yawalkar et al. Human afferent lymph from normal skin contains an increased number of mainly memory/effector CD4+ T cells expressing activation, adhesion and co‐stimulatory molecules
Nutman et al. An analysis of in vitro B cell immune responsiveness in human lymphatic filariasis.
Christmas et al. Abnormal urothelial HLA‐DR expression in interstitial cystitis
Diouf et al. IL-12 producing monocytes and IFN-γ and TNF-α producing T-lymphocytes are increased in placentas infected by Plasmodium falciparum
Nauss et al. Functional characteristics of lymphocytes isolated from the rat large intestine: Response to T-cell mitogens and natural killer cell activity
Takahara et al. iC3b arrests monocytic cell differentiation into CD1c-expressing dendritic cell precursors: a mechanism for transiently decreased dendritic cells in vivo after human skin injury by ultraviolet B
Hu et al. Changes of CD4+ CD25+ regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin
Norris et al. Systematic comparison of antibody-mediated mechanisms of keratinocyte lysis in vitro.
Geha et al. Cellular abnormalities in patients with elevated serum IgE levels
Shenker et al. Induction of human T cells that coexpress CD4 and CD8 by an immunomodulatory protein produced by Actinobacillus actinomycetemcomitans
Elster et al. Potential of costimulation‐based therapies for composite tissue allotransplantation
Loo et al. High dose antigen treatment with a peptide epitope of myelin basic protein modulates T cells in multiple sclerosis patients
Abrahamsen et al. Membrane characteristics of adherent cells dissociated from rheumatoid synovial tissue.
Hbabi et al. In vitro stimulation of polymorphonuclear cell adhesion by ribomunyl and antibiotic+ ribomunyl combinations: effects on CD18, CD35 and CD16 expression
Zafiropoulos et al. Flow‐cytometric analysis of lymphocyte subsets in patients with advanced periodontitis
Ikewaki et al. Modulation of cell surface antigens and regulation of phagocytic activity mediated by CD11b in the monocyte‐like cell line U937 in response to lipopolysaccharide
Fiorilli et al. Phenotypically immature IgG-bearing B cells in patients with hypogammaglobulinemia
Steevels et al. Effector/memory T cells of the weanling mouse exhibit type 2 cytokine polarization in vitro and in vivo in the advanced stages of acute energy deficit

Legal Events

Date Code Title Description
FZDE Discontinued